OMNIPOD INSULIN PUMP
Report
- Report Number
- 3004464228-2019-02236
- Event Type
- Malfunction
- Date Received
- March 20, 2019
- Date of Event
- February 25, 2019
- Report Date
- February 25, 2019
- Manufacturer
- INSULET CORPORATION
- Product Code
- LZG
- PMA / PMN Number
- K122953
- Product Problem
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- MA, US
- Reporter Occupation
- OTHER
Narratives
THE RETURNED DEVICE WAS EVALUATED AND NO KINKS OR BENDS WERE IDENTIFIED ON THE EXPOSED PORTION OF THE CANNULA. FLUID PATH TESTING SHOWED THAT INSULIN WAS ABLE TO PASS OUT THE DISTAL TIP OF THE SOFT CANNULA. NO OTHER DEFECTS OR DEFICIENCIES WERE IDENTIFIED DURING THE INVESTIGATION.
THE PRODUCT WAS NOT RETURNED FOR EVALUATION. WE ARE UNABLE TO CONFIRM THE REPORTED BENT CANNULA OR TO DETERMINE WHETHER IT CONTRIBUTED TO THE REPORTED HYPERGLYCEMIA. LOT RELEASE RECORDS WERE REVIEWED AND THE PRODUCT LOT MET ALL ACCEPTANCE CRITERIA. OMNIPOD INSULIN MANAGEMENT SYSTEM ¿ USER GUIDE. MODEL: CAT45E/CAT45F. 15546-AW REV D 06/2016. CHECKING YOUR BLOOD GLUCOSE 7 / PAGE 98. WARNING: IF YOU GET RESULTS BELOW 3.9 MMOL/L OR ABOVE 13.9 MMOL/L, BUT DO NOT HAVE SYMPTOMS OF HYPOGLYCEMIA OR HYPERGLYCEMIA REPEAT THE TEST. IF YOU HAVE SYMPTOMS OR CONTINUE TO GET RESULTS THAT FALL BELOW 3.9 MMOL/L OR ABOVE 13.9 MMOL/L, FOLLOW THE TREATMENT ADVICE OF YOUR HEALTHCARE PROVIDER.
IT WAS REPORTED THE PATIENT¿S BLOOD GLUCOSE REACHED BETWEEN 14, 19 TO 20 MMOL/L (252, 342 TO 360 MG/DL) AND THAT THE CANNULA WAS BENT. HYPERGLYCEMIA TREATED BY PATIENT WITH A CORRECTION BOLUS AND ACTIVATING NEW POD. INSULIN WAS LEAKING AT THE INSERTION SITE AND THAT THE ADHESIVE PAD WAS WET. THE POD WAS WORN BETWEEN 36 AND 48 HOURS ON THE LEG.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 229412 | OMNIPOD INSULIN PUMP | PUMP, INFUSION, INSULIN | LZG | INSULET CORPORATION | 15880 | L44200 |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | 18 YR |